Director, Country Operations Disease Area Lead (Alexion)

Start free →

Or apply yourself on the official page →

About the role

Director, Country Operations Disease Area Lead Location: Warsaw Hybrid Model: 3 days per week from office As Director, Country Operations Disease Area Lead (CODAL) you will provide strategic and operational expertise in assigned disease areas to global and country teams to shape optimal strategy and delivery approaches by the site management organization.  You will maintain oversight of Alexion Rare Disease portfolio key objectives and achievements for your assigned disease areas and play a key role in supporting the appropriate translation of TA strategy to operational delivery across Alexion Country Operations Management (COM) and AZ Site Management and Monitoring (SMM) functions​. In this capacity, you will serve as the central point of contact for the disease area within the country organization, supporting operational planning, delivery and issue resolution​. As the primary country operations representative for your assigned disease area, you will maintain a connection between the global stakeholders and the country organization to drive consistent delivery of high-quality trials across the full lifecycle of studies (i.e. early planning, feasibility, start-up, conduct, close-out and reporting). Collaboration and partnership are key in this position, and a pivotal accountability is to stay updated on internal and external clinical development trends.  You will also be required to engage with partners across the full portfolio at the global, regional and country levels. Responsibilities : Feasibility:  ​ • Validating optimal country footprint from initial identification through to finalization (factoring operational viability, expected cycle times, performance/reliability, resource capacity, internal capabilities)​ • Ensuring country organization is equipped with the correct level of information to perform high quality feasibility (i.e. assess what education, data, feasibility insights are required) • Inputting into the feasibility process, as required • Engaging internally and externally to drive identification of potential new investigators to expand global footprint, in alignment with TA clinical development plans   Collecting and sharing lessons learned:  • Supporting consistent operational approaches and ongoing process improvement across Alexion clinical studies from COM and SMM (based on Alexion study experience, country cycle time/performance, inspection experience/quality, etc.)   Input to disease area/indication strategy:  • Representing country organization in global forums to support effective and consistent early planning, feasibility and trial conduct across disease areas • Supporting with the preparation for governance interactions • Inputting into therapy area and asset strategy development; analyzing, consolidating, and translating country insights from local stakeholders to actionable process improvements. • Building and maintaining disease area expertise to provide operational input and impact assessment to study design, documents and plans (e.g. protocol concept sheet, protocol, clinical monitoring plan, site engagement plan, pharmacy manual, etc.) • Calculating site management resourcing needs (across COM/SMM) for Alexion studies within assigned disease areas • Embracing digital health, patient/site centricity, and recruitment and retention solutions for studies within assigned disease areas in alignment with global initiatives • Supporting study prioritization within disease areas   Identifying risks:  ​ • Maintaining awareness of delivery metrics and related Key Performance Indicators (KPIs) globally across studies to proactively identify risks and recommend timely and consistent implementation of mitigation strategies across assigned disease areas • undefined Escalation point ​ • Act

View the official posting →